NATIONAL CAUCUS OF
BASIC BIOMEDICAL SCIENCE CHAIRS

DRAFT

A Executive Summary Meeting on May 15 – 17, 2002
Association of Anatomy, Cell
Biology and Neurobiology
Chairpersons

Association of Chairmen of
Departments of Physiology

Association of Medical and
Graduate Departments of
Biochemistry

Association of Medical Schoo
Microbiology and Immunology
Chairs

Association for Medical School
Pharmacology

Association of Pathology Chairs

Association of Professors of
Human and Medical Genetics

Association of Medical School
Neuroscience Department
Chairpersons

Chairman:
H. George Mandel, Ph.D.
Professor and former Chairman
Department of Pharmacology
The George Washington
University Medical Center
2300 Eye St., NW
Washington, DC  20037
Tel:  (202) 994-3542
Fax:  (202) 994-2870

Vice Chairs:
Diana S. Beattie, Ph.D.
Professor and Chair
Department of Biochemistry
West Virginia University
School of Medicine
Morgantown, WV  26506
Tel:  304-293-7522
Fax:  304-293-6846

Antonio Scarpa, M.D., Ph.D.
Professor and Chairman
Department of Physiology and
Biophysics
Case Western Reserve
University School of Medicine
10900 Euclid Avenue
Cleveland, OH 44106-4970Tel:  
216-368-5298
Fax: 216-368-5586

                                       June 14, 2002

Dr. Charles A. Blake
Secretary, AACBNC
Dept. Cell Biology and Neuroscience
University of South Carolina
School of Medicine
Columbia, SC 29208

Dear Charlie:

I am attaching the minutes of our last Caucus
meeting held in Washington May 15-17, together with
our agenda and the list of Caucus participants. Drs.
Hendrix and Goodman attended.  I am requesting
that you disseminate this information to your
chair-members.

In brief, NIH Acting Director Kirschstein described
the complexities of the various issues facing the
NIH, and the budget needed to maintain its
productivity. We had also been briefed by
colleagues from the AAMC, FASEB, Campaign for
Medical Research and Research!America in order to
present a united front.

The issues we felt most important were:

1.  To assure that the 5-year doubling of the NIH
budget be reached in FY 2003.

2.  To introduce the idea that for subsequent years,
8-10% budgetary increases would be required to
avoid reversing progress against disease achieved
from previous increases in the NIH budget.

3.  To request sizeable increases in the budgets for
closely related disciplines complementary to the
biomedical sciences.

4.  To continue the flow of foreign scientists and
students to work with us.

5.  To assist US academic medical centers in their
financial struggles

6.  To encourage training of physician scientists and
to accelerate the translation of basic science
discoveries to the bedside.

We discussed these concerns to Dr. Marburger,
Science Adviser to President Bush and Director,
OSTP, because the Administration foresees only
inflationary budget increases (2-3% for FY 2004) for
the NIH. We also visited the offices of major
Senators and Congressmen involved in NIH
appropriations. Other visitors included Mary Woolley
(Research!America) who again stressed the
importance of  individual scientists speaking up for
the importance and achievements in health
research, especially in their own home districts; the
Honorable John  Porter, who focused our attention
on criminal features of Congressional bills on
therapeutic cloning that threaten scientists; Dr. Rita
Colwell (NSF) who described the financial plight of
that agency that supports much of science
complementary to the biomedical disciplines, and
which we strongly supported; and Tony Mazzaschi,
who is organizing an AAMC meeting of basic science
chairs. Discussions with members of BIO, the
National Health Council and other science public
affairs experts are described in the attached
minutes.

The Caucus also voted to thank Senator Hatch for
his positive stand on therapeutic cloning and its
possible health benefits, and to honor Dr.
Kirschstein with a certificate of appreciation.

Thanks for distributing this information.                  

Sincerely yours                 
H. George Mandel, Ph.D.
NATIONAL CAUCUS OF  BASIC BIOMEDICAL SCIENCE
CHAIRS

Department of Pharmacology
The George Washington University Medical Center
2300 Eye Street NW, Washington, DC  20037
Agenda - May 15 – 17,  2002
     
Wednesday, May 15

2 p.m.       Registration                                                                                        643 Ross Hall
  Plans for this meeting -  Dr. George Mandel,  Caucus
  Chair  

2:30 p.m.  Briefing for  Meetings with Political Leaders    
  Pat White, Director of Legislative Relations, FASEB
  David Moore, Associate Vice President., AAMC
  Kevin Mathis, Legislative Director, Campaign for Medical
  Research
  Bill Leinweber, Vice President, Research! America

4:30 p.m   Dr. Ruth Kirschstein, Acting Director, NIH                                     643 Ross  Hall

6:30 p.m.  Dinner with Dr. John H. Marburger, Science Adviser to                     GWU
Club                 the President (USA)  and Director, Office of Science and            1918 F
St. NW
  Technology Policy               

Thursday, May 16     

8 a.m.        Organizational Breakfast                                                                  643 Ross Hall

9:30 a.m.   GROUP A. Visit with Elizabeth Barr, Staff of                     1004  Longworth Bldg
   Congresswoman Anne Northup, House NIH
   Appropriations Subcommittee  

10 a.m       Visit with Jason Grove, Staff of Congressman Ralph          2306 Rayburn Bldg
   Regula,Chairman, NIH Appropriations Subcommittee  

10:30 a.m. Visit with Mary Scott Pearson, Staff of Congressman         2458 Rayburn Bldg
Henry Bonilla, House NIH Appropriations Subcommittee

11 a.m       Visit with Paul Pisano, Staff of Congressman Dan                  102 Cannon Bldg
   Miller, House NIH Appropriations Subcommittee  

11:45 a.m. Visit with  Brent Jaquet, Staff of Congressman                    2407 Rayburn
Bldg                  C.W.”Bill” Young, Chair, House  Appropriations
   Committee  

9:30 a.m.  GROUP B. Visit with Shalini Matami and Christina Ho,                   527 Hart Bldg
  Staff of Senator Hillary Clinton, Senate  Budget
  Committee

10:15 a.m. Visit with David Bowen, Staff of Senator Edward                          527 Hart Bldg
   Kennedy, Chairman, Senate Health Committee  

10:45 a.m. Visit with Kalynne Harvey Welsh, Staff of  Senator Kay          284 Russell Bldg
   Bailey Hutchison , Senate NIH Appropriations
   Subcommittee  

11:30 a.m. Visit with Charity Bracy, Staff of Senator Dianne                           331 Hart Bldg
   Feinstein, Senate NIH Appropriations Subcommittee  

12:30 p.m. Lunch                                                                                                  643 Ross Hall

2 p.m.        Mary Woolley, President,  Research!America                                       643 Ross

3 p.m.       The Honorable John E. Porter, Partner Hogan & Hartson,                   643 Ross
  and former Chairman, House NIH Appropriations
  Subcommittee  

4 p.m.       Michael Losow, Director, Outreach ,  Biotechnology                           643 Ross
  Industry Organization   

6:30 p.m.  Dinner, with Anthony Mazzaschi, Associate Vice                           Cosmos Club
  President, Biomedical and Health Sciences Research,          2121Mass.Av.NW
  and Director, Council of Academic Societies Affairs,   
  Association of American Medical Colleges

Friday, May 17

8:30 a.m.   Breakfast                                                                                                    643 Ross

9 a.m.        Dr. Rita R. Colwell, Director, National Science                                      643 Ross
   Foundation  

10 a.m.      Kei Koizumi,  Director R&D Budget and Policy,                                     643 Ross
   American Association for the Advancement of Science   

10:30 a.m. Brian Dougherty, Director, Office of Legislative and                           643 Ross
   Government Affairs, American Chemical  Society

11 a.m.      Paul Smedberg, Director of Government Affairs, National                  643 Ross
   Health Council

11:30 a.m. Janet Shoemaker, Director, Public Affairs, American                           643
Ross                  Society for  Microbiology

12:30 p.m.  Lunch & Adjournment                                                                              643 Ross
Executive  Summary

Meeting on May 15-17, 2002


The Caucus, comprised of presidents and other officers of associations of chairs of
the basic science departments of U.S. Medical Schools, held its annual meeting in
the Department of Pharmacology, The George Washington University School of
Medicine and Health Sciences, Washington, D.C., on May 15-17. Seventeen
representatives attended.

Before meeting with our political leaders we were briefed by local experts on the
political process regarding health research, the present status of funding for the
NIH, the dim prospects for future increases in the appropriation of health-related
governmental agencies, and the current disagreements about human cloning. This
briefing was especially important because of normal turnover of officers in our
constituent associations, so that about a third of our members at this meeting were
new to the Caucus.  David Moore, Associate Vice President, Office of Government
Relations, AAMC and a leader of the Ad Hoc Group for Medical Research Funding;
Kevin Mathis, Director of the Campaign for Medical Research; Pat White, Director of
Legislative Relations, FASEB; and Bill Leinweber, Vice President of Research!
America, reiterated the importance of thanking our political leaders for the major
increases in the NIH budget during the last 4 years, the need for accountability to
document how  this increase has led to a better life for our people, and the urgency
to translate the discoveries from the laboratory to the patient.

During her visit,   Dr. Ruth L. Kirschstein, Acting Director of the NIH described
current issues complicating budgetary projections at the NIH.  The long-range
commitments for research projects and programs, in contrast to the annual budget
appropriation, have required one-time expenditures, such as instrumentation and
buildings. Increases in the number of Institutes, the need for more clinical trials,
possible geographic funding inequities, major threats regarding military biodefense
and bioterrorism, all need careful evaluation. It has been calculated that an 8-10%
annual increase in the NIH budget would be required to maintain its activities, once
the doubling process has been completed.  A new NIH Director has just been
appointed who will now have to face these issues. Because of her long,
exceptionally able and positive leadership positions at the NIH, her understanding
service to the scientific community and her encouragement of future medical
scientists, the Caucus voted to present to Dr. Kirschstein a certificate of our
admiration and thanks.

We had the opportunity of having Dr. John H. Marburger, recently appointed as
Science Advisor to President Bush and Director of the Office of Science and
Technology, as our dinner guest. Among issues discussed was the future role of
foreign scientists and students wishing to work in the US. This matter has become
extremely complex because of national security concerns. Dr. Marburger fully
agreed that allowing eligible foreign scientists to join us is essential in preventing
disruption of ongoing research, and he was anxious to assist in this matter. We also
mentioned that there appeared to have been a recent increase in the number of
bright U.S. student applicants to enter scientific careers.

We also discussed the financial difficulties presently facing our academic health
centers and teaching hospitals. Governmental support of these precious institutions
is required to assist in the training of young physicians and other medical experts
who can rapidly translate the results of basic research into medical progress. Efforts
should be made to permit “protected time” for physician scientists to enable them to
participate actively in research.

We stressed to Dr. Marburger that once the doubling process for the NIH had been
completed, more than inflationary increases will be needed.  Although we recognize
the President’s strong support for medical research, and in spite of the present
Federal deficit, we support an 8-10% budgetary increase for the NIH to sustain the
major progress made over the last few years The present Administration plan is for a
2-3% increase.  He concurred with our opinion of major increases in support for
closely related scientific organizations, such as the NSF and the CDC.

Some of our Caucus participants then visited the offices of Congressmen Ralph
Regula, chairman of the House Appropriations Subcommittee for Labor, HHS and
Education (responsible for funding NIH), two other members in that Committee,
Representative Anne Northup, Henry Bonilla, and Congressman C.W.”Bill” Young,
chairman of the overall House Budget Appropriations Committee. Other Caucus
members visited the offices of Senators Kay Bailey Hutchison and Dianne Feinstein,
both on the Senate NIH Appropriations Subcommittee, and Senators Hillary Clinton
and Edward Kennedy, on the Senate Budget and Health Committees, respectively. In
our discussions we supported President Bush in his recommendation to complete
the 5-year doubling process for the NIH in FY 2003.  Although most of our Hill
contacts thought this would happen, final outcomes are unpredictable. We also
focused on the importance of sustaining the momentum of progress against disease,
which thereafter would require annual increases of 8-10%. In addition, we asked for
significant growth in the funding of disciplines closely related to biomedical fields,
such as chemistry, biology, physics, mathematics, engineering and information
technology. We again brought up the financial difficulties being felt by academic
health centers and teaching hospitals, and the need for the Congress to assist these
institutions.  We expressed our gratitude to our leaders in the Congress for their
generous past support of NIH and health research.

Mary Woolley, President of Research! America, stressed the importance of scientists
contacting their Congressional representatives in their home districts. The current
great emphasis on accountability can be met by demonstrating the achievements of
NIH funding in our home medical centers, which they should be asked to visit. She
also proposed scientists writing op-ed articles in local newspapers, since politicians
rarely hear from them. With the Honorable John E. Porter, former chairman of the
House NIH Appropriations Subcommittee and currently the chair of an Institute of
Medicine (IOM) Committee addressing the future role of academic health science
centers, we discussed the need for government support to permit training of young
physicians and other medical experts. He cautioned us on the consequence of a bill
currently being considered by the Senate, and already passed by the House,
prohibiting therapeutic as well as reproductive cloning that would level criminal
penalties against U.S. scientists carrying out such experiments. The Caucus voted to
support the National Academy of Sciences proposal to encourage nuclear transfer
experiments, but not reproductive cloning, and  to thank Senator Hatch, a strong
conservative, in particular. He apparently has heard from very few scientists for his
courageous stand.

Michael Losow, Director, Outreach of BIO, the Biotechnology Industry Organization,
described the successes and predicaments of this exciting industry, which depends
so heavily on basic biomedical science discoveries. Much of their work is being held
up by the lack of a Commissioner of the FDA.  Anthony Mazzaschi, Associate Vice
President, Biomedical and Health Sciences Research, and Director of the Council of
Academic Societies, AAMC, described the increasing focus by the AAMC on faculty,
and in particular chairs, and the meeting being planned for October 11, 2002 in
Philadelphia, “The Evolving Role of the Basic Science Department Chair”. The
Caucus had previously recommended that the AAMC take a more active role with
faculty. We also discussed the importance of funding health-related activities by the
CDC and the Departments of Defense and Energy.

Dr. Rita Colwell, Director of the National Science Foundation, described that agency’
s many vital programs from education to basic research in all the science disciplines,
many of which are complementary to the NIH. She noted the greater frequency of
career switches by the younger generation which requires a wider knowledge base.
The NSF is well recognized for its good management, rapid turn-around time for
many grant applications (but some of which tend to be unduly small), and willingness
to fund  some high risk but highly promising projects. Paul Smedberg, Director of
Government Affairs, National Health Council, an umbrella organization for more than
100 health-related organizations, was strongly supportive of the NIH, and as
concerned as we are about Congressional micro-management and budgetary set-
asides. Brian Dougherty, Director, Office of Legislative and Government Affairs,
American Chemical Society, expressed concern about inadequate funding for the
Department of Education supporting science and mathematics, in spite of the recent
enactment of the Education Bill. Kei Koizumi, Director of R&D Budget and Policy,
AAAS, discussed the prospects of future budget increases in view of the looming
Federal deficit. Janet Shoemaker, Director of Public Affairs, American Society for
Microbiology, described the sudden and enormous focus on their discipline by
issues of biodefense,  includingg questions on vaccination procedures, possible
criminalization of work with certain biological agents, controls over scientific
publications, and delayed clearance of foreign students. She explained that terror-
related budgetary increases would be required for several years, and would include
extensive basic research investigations. We expect to meet again in the spring of
2003.

Respectfully Submitted,

H. George Mandel, Ph.D.
Chairman
NATIONAL CAUCUS OF BASIC BIOMEDICAL SCIENCE CHAIRS
Meeting Attendees - May 15-17, 2002
Chair, NCBBSC

Dr. H. George Mandel
Professor and former
Chairman
Dept. Pharmacology
GWU School of Medicine
2300 Eye Street, NW
Washington, DC  20037
Tel:  202-994-3542
Fax:  202-994-2870
phmhgm@gwumc.edu


Association of Anatomy,
Cell Biology and
Neurobiology
Chairpersons

Dr. Mary J. C.  Hendrix (2)
Professor and Head
Dept. Anatomy & Cell
Biology
Univ. Iowa
1-100 Bowen Sci Bldg
51 Newton Rd.
Iowa City, IA 52242-1109
Tel: 319-335-7755
Fax 319-335-7770
Mary-hendrix@uiowa.edu


Dr. Steven R. Goodman
(4)
Lundell Professor and
Head
Dept.Molecular & Cell.
Biol    
Univ. Texas at Dallas    
Box 830688, F.O.3.1
Richardson, TX
75083-0688
Tel: 972-883-4872
Fax: 972-883-2409
sgoodmn@utdallas.edu


Association of Chairmen
of Departments of
Physiology

Dr. L. Gabriel Navar
Professor and Chairman
Dept. Physiology
Tulane Univ. Sch. of Med.
1430 Tulane Avenue
New Orleans, LA  
70112-2699
Tel: 504-588-5251
Fax: 504-584-2675
navar@tulane.edu

Dr. Antonio Scarpa (4)
Vice Chair, NCBBSC
Professor and Chairman
Dept. Physiol. and
Biophysics
Case Western Res. Univ.
School Of Medicine
10900 Euclid Avenue
Cleveland, OH
44106-4970
Tel: 216-368-5298
Fax: 216-368-5586
Axs15@po.cwru.edu
Association for Medical
School Microbiology and
Immunology Chairs

Dr. Richard W. Moyer (1,4)
Professor and Chairman
Dept. Molecular Genetics
and Microbiology
University of Florida
P.O. Box 100266 HSC
Gainesville, FL  
32610-0266
Tel: 352-392-7077
Fax: 352-846-2042
rmoyer@ufl.edu


Dr. John Iain Hay (3)
Professor and Chairman
Dept. Microbiol.
SUNY at Buffalo
School of Medicine
Buffalo, N.Y.,14214
Tel.: 716-829-2907
Fax: 716-829-2158
Jhay@buffalo.edu

Dr. Richard Coico (2)
Professor and Chair
Dept. Microbiol. &
Immunology
CUNY Medical School
138th St. & Convent Ave.
New York, NY 10031-9100
Tel.:  212-650-6628
Fax:  212-650-7797
Coico@med.cuny.edu


Association of Medical &
Graduate Departments of
Biochemistry


Dr. Nathan N. Aronson (1)
Professor and Chairman
Dept. Biochem. and Molec.
Biol.
University of South Alabama
307 University Boulevard
MSB 2152
Mobile, AL  36688-0002
Tel: 251-460-6402
Fax: 251-460-6127
naronson@jaguar1.usouthal.edu


Dr. Louis B. Hersh (2)
Professor and Chairman
Dept. Biochemistry
Univ. of KY Chandler Med.
Ctr.
800 Rose Street
Lexington, KY  40536-0298
Tel: 859-323-5549
Fax: 859-323-1727
lhersh@pop.uky.edu

Dr. Eugene A. Davidson
Professor & Chairman
Dept. Biochemistry
Georgetown University
3900 Reservoir Road
Washington, D.C.
20007-2197
Tel.: 202-687-1401
Fax:  202-687-7186
Davidson@georgetown.edu
Association for Medical
School Pharmacology

Dr. Arthur P. Grollman (4)
Professor and  former
Chairman
Dept. Pharmacology
SUNY at Stony Brook
BST 8, Room 140
Stony Brook, NY  
11794-8651
Tel: 631-444-3080
Fax: 631-444-7641
apg@pharm.sunysb.edu


Dr. Israel Hanin (1)
Professor and Chairman
Dept. Pharm. and Exp.
Therap.
Loyola University Chicago
Stritch School of
Medicine2160 S. First
Avenue
Maywood, IL  60153-5589Tel:
708-216-3261
Fax: 708-216-6596
ihanin@wpo.it.lumc.edu


Dr. James C. Garrison
Professor and Chair
Department of
Pharmacology
Univ. of Virginia Sch.of
Medicine
Box 448
Charlottesville, VA
22908-0001
Tel.: 434-924-5618
Fax: 434-924-5207
Jcg8w@virginia.edu



Association of
Pathology Chairs

Dr. George K.
Michalopoulos (4)
Professor and Chairman
Dept. Pathology
Univ. of Pittsburgh Sch. of
Med.
S410 BST
200 Lothrop Street
Pittsburgh, PA 15261
Tel: 412-648-1040
Fax: 412-648-9846
michalopoulosgk@msx.up
mc.edu

Dr. David S. Wilkinson
Professor and Chairman
Dept. Pathology
Virginia Commonwealth
University
Box 980662
Richmond, VA 23298-0662
Tel.: 804-828-0183
Fax:  804-828-2869
Dswilkinson@hsc.vcu.edu
Association of
Professors of Human &
Medical Genetics

Dr. Robert J. Desnick
Professor and Chairman
Dept.of Human Genetics
Mount Sinai School of
Med.
100th St., at 5th Ave.
New York, NY
10029-1809Tel.:
212-659-6700
Fax:  212-360-1809
Rjdesnick@mssm.edu

Association
(1)      President
(2)      President-Elect
(3)      Past President
(4)      CAS Representative
AACBNC